← Live Studies
CagriSema switching study in type 2 diabetes
Looks at safety and tolerability when adults with type 2 diabetes switch from semaglutide injections to investigational CagriSema. Everyone in the study receives CagriSema.
Who it's for
- Age 18+
- Type 2 diabetes
- Currently on relevant semaglutide treatment
- Study team determines fit
Full eligibility rules apply. The study team decides who can take part.
Where it runs
13 research locations in Arizona, California, Hawaii and Utah.
Arizona
- Gilbert Center For Family MedicineGilbert, AZ
California
- Ark Clinical ResearchFountain Valley, CA
- Thrive Clinical Research GroupGlendora, CA
- Scripps Whittier Diabetes InstLa Jolla, CA
- Downtown LA Res Ctr. Inc.Los Angeles, CA
- Valley Clinical Trials, Inc.Northridge, CA
- Dream Team Clinical ResearchPomona, CA
- Clinical Trials Research - SacramentoSacramento, CA
- Linda Vista Health Care CtrSan Diego, CA
Hawaii
- East West Med Res InstHonolulu, HI
Utah
- J.Lewis Research IncSalt Lake City, UT
- Diabetes & Endo Treatment SpecSandy City, UTNot yet recruiting
- Chrysalis Clinical ResearchSt. George, UT
Site recruitment may change. The official record lists every location, including outside these states.
Interested in this study?
Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.

